Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Precancerous Conditions 1Papillomavirus Infections 1Papilloma 1AIDS-related Kaposi sarcoma 1

Interventions

Sulindac 4Biopsy 4Carboplatin 3Vaginal Smears 2Cyclophosphamide 2Colposcopy 2Aspirin 2tanespimycin 1sargramostim 1pirfenidone 1fludarabine phosphate 1alethine 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Papanicolaou Test 1Mycophenolic Acid 1Microarray Analysis 1Lovastatin 1Interleukin-12 Subunit p35 1Interferon-alpha 1Inositol 1Ifosfamide 1Genetic Linkage 1Gene Expression Profiling 1Fluorophotometry 1FANG vaccine 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Precancerous Conditions × Cidofovir × Clear all
NCT00811408 2010-01-28

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Unknown
24 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡